Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Revenue
Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending March 31, 2025, Blueprint Medicines generated $149.41M in revenue.
Revenue (ttm)
508.82M
Revenue Growth
104.04%
Price / Sales Ratio
10.77
Revenue / Employee
746.08K
Employees
682
Market Cap
8.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 508.82M | +104.04% |
| Dec 31, 2023 | 249.38M | +22.22% |
| Dec 31, 2022 | 204.04M | +13.30% |
| Dec 31, 2021 | 180.08M | -77.31% |
| Dec 31, 2020 | 793.74M | +1093.37% |
| Dec 31, 2019 | 66.51M | +49.39% |
| Dec 31, 2018 | 44.52M | +107.79% |
| Dec 31, 2017 | 21.43M | -22.85% |
| Dec 31, 2016 | 27.77M | +143.61% |
| Dec 31, 2015 | 11.4M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |